<DOC>
	<DOC>NCT01442987</DOC>
	<brief_summary>The purpose of this study is to evaluate efficacy and safety of coadministered Irbesartan and Atorvastatin in patients with hypertension and hyperlipidemia.</brief_summary>
	<brief_title>Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Aged between 19 and 75 years Signed informed consent At screening, SPB ≥ 180mmHg or DBP ≥ 110mmHg or LDLC &gt; 250mg/dL or TG ≥ 400mg/dL Has a history of hypersensitivity to Angiotensin Ⅱ receptor blocker or HMGCoA reductase inhibitor or component of this drug Has a history of multidrug allergy</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Irbesartan</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Hyperlipidemia</keyword>
</DOC>